NCT02891460
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- Rajiv Gandhi Cancer Institute & Research Center Delhi, New Delhi, India
Clinical trial condition
Urinary Bladder Neoplasms
Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.
67 public trials
15 recruiting studies
Urinary Bladder Neoplasms trial results
NCT02252445
- Conditions
- Anesthesia, Catheter Site Discomfort, Complications, +11 more
- Locations
-
- Seolu National University of Hospital Seoul, South Korea
NCT00625664
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
- Locations
-
- Sanofi-Aventis Investigational Site Number 840068 Anchorage, Alaska, United States
- Sanofi-Aventis Investigational Site Number 840035 Berkeley, California, United States
- Sanofi-Aventis Investigational Site Number 840012 Burbank, California, United States
- Sanofi-Aventis Investigational Site Number 840029 La Jolla, California, United States
NCT02381912
- Conditions
- Erectile Dysfunction, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +19 more
- Locations
-
- Herlev Hospital Herlev, Denmark
NCT02427321
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
- Locations
-
Not specified
NCT02096224
- Conditions
- Anesthesia, Catheter Site Discomfort, Complications, +11 more
- Locations
-
- Seoul National University of Hospital Seoul, South Korea
NCT02238886
- Conditions
- Bladder Cancer, Cystectomy, Female Urogenital Diseases, +14 more
- Locations
-
- Dep. of Urology. University Hospital Rigshospitalet, Copenhagen Denmark Copenhagen, Denmark
Active, Not Recruiting
Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment
NCT04706598
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Immunotherapy, +9 more
- Locations
-
- Shanghai Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
- Shanghai Tenth People's Hospital,Shanghai Tong Ji University School of Medicine Shanghai, Shanghai Municipality, China
- Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Active, Not Recruiting
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
NCT04658862
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
- Locations
-
- Loma Linda Univ Faculty Medic Loma Linda, California, United States
- University of Southern California Los Angeles, California, United States
- Providence Saint John s Health Center Santa Monica, California, United States
- Stanford University Medical Center Stanford, California, United States
Active, Not Recruiting
A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer
NCT05567185
- Conditions
- Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +22 more
- Locations
-
- St Marianna University Hospital Kanagawa, Japan
- Osaka International Cancer Institute Osaka, Japan
- Toyama University Hospital Toyama, Japan
- University of Tsukuba Hospital Tsukuba, Japan